L Morbidelli

Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.

R Bicknell, H. Granger, S. Donnini, 1997, The Journal of clinical investigation.

The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo

R Bicknell, H. Turley, L. Morbidelli, 2000, British Journal of Cancer.

Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic.

H. Granger, G. Viglietto, D. Ribatti, 1997, Laboratory investigation; a journal of technical methods and pathology.

Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases.

A Vacca, D. Ribatti, L. Morbidelli, 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Endothelial cells in culture: a model for studying vascular functions.

L. Morbidelli, T. Bachetti, L Morbidelli, 2000, Pharmacological research.

Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.

S Amerini, H. Granger, E. Masini, 1994, The Journal of clinical investigation.